Melanoma

OncLive TV - A Network of Your Peers

Dr. Cohen Discusses Hedgehog Pathway Inhibition

Dr. Mills Gives Examples of Unexpected Drug Responses

Dr. Goy Highlights Recent Advances in Oncology

Dr. Hendrix on Metastatic Cells in Microenvironments

Dr. Hoos Discusses the Next Steps for Ipilimumab

>>> More Melanoma Videos

Targeted Therapies Yield Most Promising Results: A New Era in Melanoma Treatment Has Begun

Melanoma is one of the most frequent cancers; more than 2 million Americans are treated for skin cancer annually.

Oncology & Biotech News > Feature Article

Melanoma Breakthroughs Among Top 2011 Cancer Advances

Two novel treatments for advanced melanoma, ipilimumab (Yervoy) and vemurafenib (Zelboraf), were among the top breakthroughs in cancer research in 2011.

Oncology & Biotech News > News

Vismodegib, First Hedgehog Inhibitor, Approved for BCC Patients

The FDA has approved vismodegib for the treatment of patients with basal cell carcinoma.

> Web Exclusives

Researchers Discover Basis for Secondary Skin Cancers in Patients Taking Vemurafenib

The molecular basis behind the relatively high incidence of secondary skin cancers after patients received vemurafenib has been discovered.

> Web Exclusives

Study Supports Smaller Margins in Excising Thicker Melanomas

Patients with a primary cutaneous melanoma thicker than 2 mm can be safely treated with a 2-cm resection margin.

Oncology Live > Specialty Focus

NICE's Reluctance to Back Yervoy Turns on Cost-Benefit Perceptions

NICE has issued a draft recommendation against Yervoy approval, stating it does not show benefits to justify its costs.

Oncology Live > Specialty Focus

>>> Click here for more articles

Clinical Endocrinology Conference Coverage Coming Soon

Conferences > Clinical Endocrinology 2012

Noted Researcher Sees ERT as Remarkable Beginning

Conferences > Updates From the ICHG/ASHG 61st Annual Meeting

Same Mission, New Role for Genzyme Executive: Head of Rare Diseases Committed to Patients

Conferences > Updates From the ICHG/ASHG 61st Annual Meeting

Lysosomal Storage Disorders: Marking Milestones and Moving Forward

Conferences > Updates From the ICHG/ASHG 61st Annual Meeting

Ponatinib Continues March to Potential Front-line Use in CML

Conferences > 2011 ASH Annual Meeting and Exposition

Bringing the Oncology Community Together

Melanoma

OncLive TV - A Network of Your Peers

Latest Melanoma Articles

Melanoma Resources

Latest Oncology Meeting Highlights

Oncology Publications